Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
---|
01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
01/07/2010 | WO2010000372A2 New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
01/07/2010 | WO2009121535A3 Antiproliferative compounds and therapeutic uses thereof |
01/07/2010 | US20100004462 Process for preparing (meth)acrylic esters of n-hydroxyalkylated imidazoles |
01/07/2010 | US20100004461 Compounds containing organofluorochlorophosphate anions |
01/07/2010 | US20100004460 Method for producing 2-nitroimidazole derivative |
01/07/2010 | US20100004428 Method of Preparing Propionic Acid-Terminated Polymers |
01/07/2010 | US20100004305 Naphthylmethylimidizoles as therapeutic agents |
01/07/2010 | US20100004263 Mtp inhibiting aryl piperidines or peperazines substituted with5-membered heterocycles |
01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
01/07/2010 | US20100004159 Substituted imidazolone derivatives, preparations and uses |
01/07/2010 | CA2726999A1 New drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
01/06/2010 | EP2141151A1 Method for producing 2-haloimidazole compound |
01/06/2010 | EP2139865A1 Solid forms of (e) -1- (4- ( (ir, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime |
01/06/2010 | EP2139864A2 Methods of preparing 1-(4-(1-hydroxyalkyl)-1h-imidazol-2-yl)ethanone oxime compounds |
01/06/2010 | EP2139863A2 Method for producing (meth)acrylates of n-hydroxyalkylated imidazoles |
01/06/2010 | CN100577163C Compounds effecting glucokinase |
01/05/2010 | US7642290 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
01/05/2010 | US7642280 Inhibitors of acyl glucosaminyl inositol amidase and methods of use |
01/05/2010 | US7642279 Atipamezole hydrochloride crystallization method |
01/05/2010 | US7642277 Non-nucleoside reverse transcriptase inhibitors |
01/05/2010 | US7642267 Benzimidazole and pyridylimidazole derivatives |
01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
12/31/2009 | US20090326240 Iron-Copper Co-Catalyzed Process for Carbon-Carbon or Carbon-Heteroatom Bonding |
12/31/2009 | US20090326228 Compositions containing ionic liquids and their uses, in particular in organic synthesis |
12/31/2009 | US20090326030 Use of Levo-Ornidazole in the Preparation of Anti-Anaerobic Bacteria Infection Drugs |
12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
12/31/2009 | US20090326020 Compounds for treatment of cancer |
12/31/2009 | US20090326018 2-Phenyl indene derivatives useful as estrogen receptor ligands |
12/31/2009 | US20090325979 Novel imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof |
12/30/2009 | WO2009158011A1 Alkynyl alcohols as kinase inhibitors |
12/30/2009 | WO2009131654A3 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives |
12/30/2009 | EP2138480A1 Method for production of n-(2-amino-1,2-dicyanovinyl)imidate, method for production of n-(2-amino-1,2-dicyanovinyl)formamidine, and method for production of aminoimidazole derivative |
12/30/2009 | EP2137161A1 AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5- PHENYLIMIDAZOLONE COMPOUNDS AS ß-SECRETASE INHIBITORS |
12/30/2009 | EP1618380B1 N epsilon AND/OR N alpha DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH (M(OH2)3(CO)3)+ BY FAC COORDINATION |
12/30/2009 | EP1202973B1 Preparation of compounds useful for the detection of hypoxia |
12/30/2009 | CN101616899A Method for producing (meth)acrylates of n-hydroxyalkylated imidazoles |
12/30/2009 | CN101616898A Cyclic guanidine ionic liquid |
12/30/2009 | CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
12/30/2009 | CN101613320A 2-substituted imidazole compound and preparation method thereof |
12/30/2009 | CN101613319A Method for preparing halogenated-imidazole ionic liquid |
12/30/2009 | CN100575330C Novel compounds |
12/30/2009 | CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
12/30/2009 | CA2728767A1 Alkynyl alcohols as kinase inhibitors |
12/29/2009 | US7638637 Orally available sphingosine 1-phosphate receptor agonists and antagonists |
12/29/2009 | US7638636 Phosphonium and imidazolium salts and methods of their preparation |
12/29/2009 | US7638546 Imidazolyl derivatives |
12/29/2009 | US7638508 Glucocorticosteroid compound having anti-inflammatory activity |
12/29/2009 | CA2338543C Method of direct identification of compound efficacy at a g protein-coupled orphan receptor |
12/24/2009 | DE112007003375T5 Imidazolderivate, die Apoptose induzieren, und deren therapeutische Anwendung Imidazole derivatives induce apoptosis, and their therapeutic use |
12/23/2009 | WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses |
12/23/2009 | WO2009153566A1 Cyp26 inhibitors |
12/23/2009 | WO2009153516A1 Novel derivatives of pyrroloindole inhibitors of hsp90, compositions containing same, and use thereof |
12/23/2009 | WO2009152906A2 Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions |
12/23/2009 | WO2008152331A9 Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology |
12/23/2009 | EP2135862A1 Cyclic guanidine ionic liquid |
12/23/2009 | EP2134694A1 Imidazolium-type ionic oligomers |
12/23/2009 | EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
12/23/2009 | EP1709037B1 Hiv protease inhibiting sulfonamides |
12/23/2009 | CN101611017A Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
12/23/2009 | CN101611016A Talarazole metabolites |
12/23/2009 | CN101610675A Chemical compounds |
12/23/2009 | CN101607942A Novel imidazolone anti-tumor compound and preparation method thereof |
12/23/2009 | CN100572385C Salts comprising cyanoborate anions |
12/23/2009 | CN100572363C New imidazole derivative, method for producing the same and use of the same |
12/23/2009 | CN100572362C Diphenyl-imidazole compound and its preparing method |
12/23/2009 | CA2728476A1 Heterocyclic compound and use thereof |
12/23/2009 | CA2727626A1 Novel derivatives of pyrroloindole inhibitors of hsp90, compositions containing same, and use thereof |
12/22/2009 | US7635742 Modified isocyanates |
12/22/2009 | US7635595 Boronic acid, arsenious acid, telluric acid or germanic acid as a chelator group attached to an aromatic system; fast and reversible interaction with sugars; monitoring glucose levels in a transparent media, medical diagnostic techniques |
12/22/2009 | CA2445749C Dyeing agents for keratin fibers, containing n-heteroarylmethyl-m-phenylenediamine deritaves, as well as new n-heteroarylmethyl-m-phenylenediamine derivatives |
12/22/2009 | CA2434813C Imidazole derivatives |
12/22/2009 | CA2346847C Novel imidazoles with anti-inflammatory activity |
12/22/2009 | CA2290744C Cyclic diamine compounds and medicine containing the same |
12/17/2009 | WO2009152025A1 Imidazole derivatives useful as inhibitors of faah |
12/17/2009 | WO2009151016A1 Method for producing 1-biphenylmethylimidazole compound |
12/17/2009 | WO2009150248A1 Compounds which can be used for the treatment of cancers |
12/17/2009 | WO2009150109A1 Imidazolidine derivatives |
12/17/2009 | US20090312559 Catalytic enantioselective silylations of substrates |
12/17/2009 | US20090312382 Novel imidazolidine derivatives |
12/17/2009 | US20090312381 Substituted Arylimidazolone and Triazolone as Inhibitors of Vasopressin Receptors |
12/17/2009 | US20090312375 Heterocyclic compounds, compositions comprising them and methods of their use |
12/17/2009 | US20090312326 Substituted imidazoles |
12/17/2009 | US20090312308 Compounds and compositions as hedgehog signaling pathway modulators |
12/17/2009 | US20090312307 Heterocyclo inhibitors of potassium channel function |
12/17/2009 | US20090312276 Compositions and Methods for Treating Cancer |
12/17/2009 | CA2727607A1 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
12/17/2009 | CA2727296A1 Compounds which can be used for the treatment of cancers |
12/17/2009 | CA2727245A1 Imidazole derivatives useful as inhibitors of faah |
12/17/2009 | CA2727220A1 Method for producing a 1-biphenylmethylimidazole compound |
12/17/2009 | CA2726158A1 Compounds and compositions useful for the treatment of malaria |
12/17/2009 | CA2725654A1 Imidazolidine derivatives |
12/16/2009 | CN101605765A Controlled release of active aldehydes and ketones from equilibrated dynamic mixtures |
12/16/2009 | CN101605756A Water-soluble prodrugs of florfenicol and its analogs |
12/16/2009 | CN101602731A Metalloproteinase inhibitors |
12/16/2009 | CN101602730A Substituted imidazole derivative |
12/16/2009 | CN100569766C Difluorobenzo-1,3-dioxoles |
12/16/2009 | CN100569754C Synthesis and application of serial ion liquid as candidate drug with anticancer activity |
12/15/2009 | CA2450443C Solvent extraction mixture for the purification of base metals |
12/10/2009 | WO2009146607A1 A preparation method of (4s,5r)-semiester |